Skip to content

A single visit study multicentre study to study the diabetes related medical conditions among 10000 patients with no intervention

Cross-sectional observational multicentre pan India real-world study in patients living with T2DM to understand the prevalence of key diabetes associated comorbidities and to analyze the characteristics of such patients (INSIGHTS) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100054
Enrollment
10000
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Cipla Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients more than or equal to 18 years of age Previously diagnosed with T2DM and under the treating doctor s care for at least 3 months coming for follow-up and undergoing treatment Willing to provide written informed consent and comply with the study procedures

Exclusion criteria

Exclusion criteria: Patients with T1DM and/or Gestational diabetes mellitus Pregnant or lactating women or those planning pregnancy during the study period Participants in another clinical trial

Design outcomes

Primary

MeasureTime frame
To understand the prevalence of key diabetes associated comorbidities such as ASCVD Heart Failure CKD Obesity in patients with T2DM Timepoint: Baseline

Secondary

MeasureTime frame
To understand the patient demographics personal or clinical history clinical parameter or biochemistry drug therapy diabetes and comorbidities of the study populationTimepoint: Baseline

Countries

India

Contacts

Public ContactDr Senthilnathan Mohanasundaram

Cipla House

sandesh.sawant3@cipla.com7738384694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026